Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus
Abstract Ischemia reperfusion (IR) injury may be attenuated through succinate dehydrogenase (SDH) inhibition by dimethyl malonate (DiMAL). Whether SDH inhibition yields protection in diabetic individuals and translates into human cardiac tissue remain unknown. In isolated perfused hearts from 24 wee...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb3202da68854c63bc7f4b39308a071c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:cb3202da68854c63bc7f4b39308a071c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:cb3202da68854c63bc7f4b39308a071c2021-12-02T17:44:55ZCardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus10.1038/s41598-020-67247-42045-2322https://doaj.org/article/cb3202da68854c63bc7f4b39308a071c2020-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-67247-4https://doaj.org/toc/2045-2322Abstract Ischemia reperfusion (IR) injury may be attenuated through succinate dehydrogenase (SDH) inhibition by dimethyl malonate (DiMAL). Whether SDH inhibition yields protection in diabetic individuals and translates into human cardiac tissue remain unknown. In isolated perfused hearts from 24 weeks old male Zucker diabetic fatty (ZDF) and age matched non-diabetic control rats and atrial trabeculae from patients with and without diabetes, we compared infarct size, contractile force recovery and mitochondrial function. The cardioprotective effect of a 10 minutes DiMAL administration prior to global ischemia and ischemic preconditioning (IPC) was evaluated. In non-diabetic hearts exposed to IR, DiMAL 0.1 mM reduced infarct size compared to IR (55 ± 7% vs. 69 ± 6%, p < 0.05). Mitochondrial respiration was reduced by DiMAL 0.6 mM compared to sham and DiMAL 0.1 mM (p < 0.05). In diabetic hearts an increased concentration of DiMAL (0.6 mM) was required for protection compared to IR (64 ± 13% vs. 79 ± 8%, p < 0.05). Mitochondrial function remained unchanged. In trabeculae from humans without diabetes, IPC and DiMAL improved contractile force recovery compared to IR (43 ± 12% and 43 ± 13% vs. 23 ± 13%, p < 0.05) but in patients with diabetes only IPC provided protection compared to IR (51 ± 15% vs. 21 ± 8%, p < 0.05). Neither IPC nor DiMAL modulated mitochondrial respiration in patients. Cardioprotection by SDH inhibition is possible in human tissue, but depends on diabetes status. The narrow therapeutic range and discrepancy in respiration between experimental and human studies may limit clinical translation.Nichlas Riise JespersenMarie Vognstoft HjortbakThomas Ravn LassenNicolaj Brejnholt StøttrupJacob JohnsenPernille Tilma TonnesenSteen LarsenHans-Henrik KimoseHans Erik BøtkerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-15 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Nichlas Riise Jespersen Marie Vognstoft Hjortbak Thomas Ravn Lassen Nicolaj Brejnholt Støttrup Jacob Johnsen Pernille Tilma Tonnesen Steen Larsen Hans-Henrik Kimose Hans Erik Bøtker Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus |
description |
Abstract Ischemia reperfusion (IR) injury may be attenuated through succinate dehydrogenase (SDH) inhibition by dimethyl malonate (DiMAL). Whether SDH inhibition yields protection in diabetic individuals and translates into human cardiac tissue remain unknown. In isolated perfused hearts from 24 weeks old male Zucker diabetic fatty (ZDF) and age matched non-diabetic control rats and atrial trabeculae from patients with and without diabetes, we compared infarct size, contractile force recovery and mitochondrial function. The cardioprotective effect of a 10 minutes DiMAL administration prior to global ischemia and ischemic preconditioning (IPC) was evaluated. In non-diabetic hearts exposed to IR, DiMAL 0.1 mM reduced infarct size compared to IR (55 ± 7% vs. 69 ± 6%, p < 0.05). Mitochondrial respiration was reduced by DiMAL 0.6 mM compared to sham and DiMAL 0.1 mM (p < 0.05). In diabetic hearts an increased concentration of DiMAL (0.6 mM) was required for protection compared to IR (64 ± 13% vs. 79 ± 8%, p < 0.05). Mitochondrial function remained unchanged. In trabeculae from humans without diabetes, IPC and DiMAL improved contractile force recovery compared to IR (43 ± 12% and 43 ± 13% vs. 23 ± 13%, p < 0.05) but in patients with diabetes only IPC provided protection compared to IR (51 ± 15% vs. 21 ± 8%, p < 0.05). Neither IPC nor DiMAL modulated mitochondrial respiration in patients. Cardioprotection by SDH inhibition is possible in human tissue, but depends on diabetes status. The narrow therapeutic range and discrepancy in respiration between experimental and human studies may limit clinical translation. |
format |
article |
author |
Nichlas Riise Jespersen Marie Vognstoft Hjortbak Thomas Ravn Lassen Nicolaj Brejnholt Støttrup Jacob Johnsen Pernille Tilma Tonnesen Steen Larsen Hans-Henrik Kimose Hans Erik Bøtker |
author_facet |
Nichlas Riise Jespersen Marie Vognstoft Hjortbak Thomas Ravn Lassen Nicolaj Brejnholt Støttrup Jacob Johnsen Pernille Tilma Tonnesen Steen Larsen Hans-Henrik Kimose Hans Erik Bøtker |
author_sort |
Nichlas Riise Jespersen |
title |
Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus |
title_short |
Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus |
title_full |
Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus |
title_fullStr |
Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus |
title_full_unstemmed |
Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus |
title_sort |
cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/cb3202da68854c63bc7f4b39308a071c |
work_keys_str_mv |
AT nichlasriisejespersen cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus AT marievognstofthjortbak cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus AT thomasravnlassen cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus AT nicolajbrejnholtstøttrup cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus AT jacobjohnsen cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus AT pernilletilmatonnesen cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus AT steenlarsen cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus AT hanshenrikkimose cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus AT hanserikbøtker cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus |
_version_ |
1718379613458006016 |